January 2013
TOP LINE NEWS
The Stop TB Partnership encourages partners and friends to vote in two influential global surveys on the post-2015 development agenda.
Kicking off the new year, GDF has secured lower prices for second-line drugs and is now offering microscopes with LED fluorescence.
A review published in The Cochrane Library, which assesses the diagnostic accuracy of the Xpert test, has found it can accurately and quickly detect TB.
Ministers of Health place focus on TB, including multidrug-resistant TB and TB/HIV, as major health threats in need of urgent attention.
UNITAID has provided TB Alliance with a three-year grant to accelerate the development of pediatric TB regimens.
Partners have reported results from operational research projects in Benin, the Democratic Republic of Congo and Zimbabwe.
The United States President’s Emergency Plan for AIDS Relief has announced US $11 million to provide Xpert MTB/RIF instruments and test cartridges.
TB PEOPLE
Gary Cohen, Executive Vice President of Becton, Dickinson and Company has been appointed CEO of the MDG Health Alliance and acting CEO of GBC Health.
The Omani embassy in Jordan has teamed up with TB Champion Rania Ismail to provide support to Syrian refugees at the Zaatari camp in northern Jordan.
An event organized by Global Health and Diplomacy and Roll Back Malaria focused on TB as a major health and development challenge for Afghanistan
Former Director of TB Prevention and Control for the Massachusetts Department of Public Health succeeds John Seggerson as Executive Director.
Chief Scientific Officer Dr Tom Evans will serve as interim CEO while Aeras’s Board of Directors selects a permanent successor.
Advocate David Bryden interviews doctors and nurses who are working to stop TB and, in some cases, have become ill with the disease themselves.
The International Union Against Tuberculosis and Lung Disease has elected four new members to serve on its board of directors.
KNCV Tuberculosis Foundation's Emmy van der Grinten and Gidado Mustapha have received Gold Awards from Nigeria’s national TB and leprosy programme.
NEWS FROM OUR PARTNERS
Danielle Doughman from ACTION argues that we can learn a lot from the disability community about using more inclusive language.
The meeting provided a forum to share data, conclusions and research models from studies being carried out in countries on the Xpert diagnostic.
The Development of Ukraine foundation has launched the second wave of an information campaign that aims to reduce TB-associated stigma.
The Main Medical Department of the Azerbaijani Ministry of Justice hosted a series of visits in 2012 aimed at sharing best practice on TB care in prisons.
Vaccine developer ImmBio has entered into a research, co-development and license arrangement with the Lanzhou Institute of Biological Products.
Viet Nam’s National TB Programme, in collaboration with PATH, has announced the winners of two national painting contests for children and artists.
The vaccine candidates MTBVAC and HBHA have been awarded financial support for further development.
The Attention project of BEMFAM Family Welfare in Brazil has come to completion, having achieved the training of more than 1300 health professionals.
PASADA, an NGO working with communities affected by HIV/AIDS, has recruited a number of former patients to help provide TB/HIV services.
ANNOUNCEMENTS
The World Health Organization and the Stop TB Partnership are recruiting two new members to serve on the Global Green Light Committee.
The Tuberculosis Vaccine Initiative has opened a call for applications from organizations wishing to test vaccine candidates.
The deadline for submissions to the REACH-Lilly MDR-TB Partnership Media Awards is Friday 2 February.
PUBLICATIONS
The Union and Médecins sans Frontières have published a second edition of the guide DR-TB drugs under the microscope: sources and prices of medicines.
Review in PLOS Medicine concludes that rigorous operational research would support the implementation of WHO-recommended TB interventions.
New manual is aimed at directors and managers of laboratories and TB programmes as well as laboratory technicians who test for TB.
Two new publications on Xpert by WHO authors
Articles in the European Respiratory Journal cover the cost and affordability of Xpert and evidence, policy making and global implementation.
The CORE Group has published a handbook for nongovernmental organizations and civil society organizations that are considering joining the fight against TB.
No comments:
Post a Comment